We just released a new one-page guide on how the Trump administration and Congress can build on the momentum of the 2026 Special 301 Report. Check it out! 👇
usij.org/usij-one-pager-turn…
The beneficiary of the PTAB’s inconsistency is a large, often foreign, infringer, while the victim is an American innovator. Learn more in our recent report: buff.ly/ain5Wyc
"Last year, Trump negotiated a deal that will require Britain to increase what it pays for new medicines by 25%. As Britain contributes more toward developing new medicines, the cost burden on the United States will decrease.
The administration is also laying the groundwork for a similar agreement with Germany. In June, it launched a formal investigation into how Germany's drug price controls have harmed American commerce. This investigation will give American trade officials the leverage they need to negotiate fairer pricing policies and practices with German policymakers."
Read more from fmr Deputy USTR Jeff Gerrish in @FoxNews: buff.ly/3sPkUKQ
Learn why we support the PREVAIL Act: buff.ly/QqqZPPm
Without reform, Big Tech will continue to exploit American inventors, and the U.S. will fall behind in global innovation. The PREVAIL act can help fix this, reforming the @USPTO’s PTAB to stop #BigTech abuse and ensuring smaller innovators can thrive. #PatentsMatter
Overall growth in venture capital investment can obscure an important trend: a declining share of funding is flowing to R&D-intensive sectors such as semiconductors, fiber optics, drug discovery, networking equipment, medical devices, biotechnology, and computer hardware. These are foundational technologies with significant implications for U.S. economic competitiveness and national security.
Learn more: buff.ly/ZR9637g
ICYMI: We recently filed an amicus brief urging the federal circuit to restore injunctive relief to patent owners.
Check it out here: buff.ly/Uj3OmQQ
Our latest LinkedIn post delves into how international trade policy can boost American innovation.
Check it out here: buff.ly/P0kS2nv
.@USIJorg supports legislation like the PREVAIL Act, which would restore balance to America’s patent system by making much-needed reforms to the USPTO’s Patent Trial and Appeal Board (PTAB).
Learn more about our goals: buff.ly/ZR9637g
💡 💡 💡
Intellectual Property Month offers an opportunity to celebrate the inventions that have shaped American life and the IP rights that enabled their success.
Our latest blog post highlights four patents that made history, from the nation's first patent to the sports bra.
Read it:
c4ip.org/celebrating-ip-mont…
Without reliable patent protections in critical fields such as life sciences, AI, robotics, and advanced communications, the United States risks losing its leadership in the technologies that will shape the future. The U.S. patent system needs to reclaim its role as the global gold standard.
Learn more: buff.ly/ZR9637g
"If USTR succeeds in securing meaningful reforms in Germany, it will send a powerful signal that the United States is willing to use its trade leverage to protect American intellectual property and stand up for the workers, businesses, and investors driving medical innovation."
Learn more in our newest LinkedIn post: buff.ly/P0kS2nv
"Big Tech keeps crying wolf about predatory litigation while the real victims -- the innovators who power America’s economy -- are left unprotected.”
See @USIJorg's own Chris Israel's op-ed for @InsideSourcesDC:
buff.ly/RsA8p5K
Our new website is now live! Check it out: usij.org/
Patent protections give startups a foothold in the marketplace and help prevent larger companies and foreign competitors from simply appropriating their innovations and driving them out of the market.
Learn more: buff.ly/ZR9637g
.@USIJorg urges federal policymakers to restore confidence in the U.S. patent system by advancing reforms that recognize the unique needs of startups, entrepreneurs, and inventors and ensure their patents are strong, reliable, and enforceable.
Read more about our principles: buff.ly/ZR9637g
.@USIJorg's Chris Israel testified before the USPTO earlier this year, urging the agency to finalize its proposed PTAB reforms.
Check out his testimony: buff.ly/K19LLR4
ICYMI: Former Deputy USTR Jeff Gerrish penned a new op-ed for @FoxNews last month -- where he argued that President Trump can lower drug prices by targeting foreign free-riding abroad.
Give it a read: buff.ly/3sPkUKQ
It is critical that Congress restores faith in our patent system, reclaiming its role as the global gold standard. Learn more about @USIJorg's principles: buff.ly/ZR9637g
Lawmakers must give inventors the tools and protections they need to bring new ideas to fruition. Check out our recommendations to Congress and the White House: buff.ly/5X1Ihe7




